Clinical Trials Logo

Filter by:
NCT ID: NCT06290024 Recruiting - Pain Clinical Trials

A Multi-center Clinical Longitudinal Study of Neuropathic Pain by Collecting Data

Start date: August 15, 2023
Phase:
Study type: Observational [Patient Registry]

A multi-center clinical longitudinal study of neuropathic pain by collecting data on patients' brain physiology and cognitive function

NCT ID: NCT06290011 Recruiting - Pain Clinical Trials

A Clinical Study on the Efficacy of Cognitive Distraction Focus Relaxation Therapy Based on MR

Start date: October 11, 2023
Phase:
Study type: Observational [Patient Registry]

A prospective, single blind, randomized, parallel controlled trial was conducted to evaluate the analgesic effect and safety of MR based "cognitive distraction focus relaxation therapy" in patients clinically diagnosed with chronic moderate to severe pain

NCT ID: NCT06289803 Recruiting - Pancreatic Cancer Clinical Trials

The Application of Probe Confocal Laser Endomicroscopy in Pancreatic Tumor Surgery

Start date: September 1, 2023
Phase: N/A
Study type: Interventional

Aim of the study: To evaluate the value of Probe Confocal Laser Endomicroscopy (PCLE) in surgery for pancreatic tumor. Methods: Patients who are diagnosed with pancreatic tumor based on preoperative radiographic findings and will undergo radical resection are included in this clinical study. PCLE will be used in surgery to identify tumor is malignant or not, and surgeons will decide procedures of surgery based on outcomes of PCLE. In this present study, clinical trials will be divided into two phases. In the first phase, based on the definitive postoperative pathologic diagnosis, characteristic imaging structures that were collected by PCLE will be identified and primary diagnostic imaging criteria for pancreatic cancer would be developed. In the second phase, this criterion will be used for rapid intraoperative diagnosis of pancreatic cancer and predicting status of resection margin. In addition, accuracy of PCLE will be verified based on postoperative pathologic reports.

NCT ID: NCT06289530 Recruiting - Clinical trials for Postoperative Pancreatic Fistula

Association Between Perioperative Blood and Interstitial Fluid Glucose Level and Clinically Relevant Postoperative Pancreatic Fistula in Different Pancreatic Surgeries

CR-POPF
Start date: March 1, 2024
Phase:
Study type: Observational

This observational study was conducted in patients undergoing elective pancreaticoduodenectomy or distal pancreatectomy. It mainly answers the following two main questions: 1. What are the risk factors for clinically relevant postoperative pancreatic fistula in different pancreatic surgeries? 2. What is the correlation between perioperative blood and interstitial fluid glucose level and clinically relevant postoperative pancreatic fistula in different pancreatic surgeries? Participants were not required to perform additional research work other than the usual postoperative follow-up within 30 days after surgery. No control group was set in this study, and no additional clinical intervention was performed.

NCT ID: NCT06289452 Recruiting - Eye Diseases Clinical Trials

Safety and Efficacy Study of IVB102 Injection in Subjects With X-linked Retinoschisis

Start date: March 8, 2024
Phase: Early Phase 1
Study type: Interventional

The goal of this clinical trial is to evaluate the safety and efficacy of IVB102 injection in subjects with XLRS.

NCT ID: NCT06289166 Recruiting - Hemophilia Clinical Trials

Safety and Efficacy of STSP-0601 in Adult Patients With Hemophilia A or B With Inhibitor

Start date: March 18, 2024
Phase: Phase 2
Study type: Interventional

This study will assess the safety and efficacy of multiple-dose of STSP-0601 for the treatment of bleeding episodes in hemophilia A or B patients with inhibitor.

NCT ID: NCT06288841 Recruiting - Clinical trials for Pharmacological Action

Efficacy and Safety of Liposomal Bupivacaine Under ERAS Concept for Postoperative Analgesia of Ultrasound-Guided QLB in Gynecologic Laparoscopic Patients: A Randomized, Single-blind, Active-Controlled Clinical Study

Start date: November 30, 2023
Phase: N/A
Study type: Interventional

With the development of the concept of comfortable medicine and enhanced recovery surgery (ERAS), optimizing the perioperative management of patients, reducing surgical stress, and reducing postoperative pain can effectively reduce perioperative complications and achieve the purpose of accelerating recovery. As an important part of ERAS, multimodal analgesia is the core concept of perioperative analgesia management. As a kind of perioperative multimodal analgesia, quadratus lumbar muscle block (QLB) is a type of local anesthetic drug injected around the quadratus lumbar muscle to reduce or eliminate abdominal wall pain and visceral pain after abdominal surgery. QLB has been used successfully for pain control after laparoscopic and open surgery, reducing perioperative opioid use and improving prognosis-related measures such as PONV and length of hospital stay. Bupivacaine liposomes use DepoFoam technology to encapsulate the drug in polycystic liposomes, which can prolong the release time of bupivacaine due to the different rupture times of different vesicles, and the postoperative analgesia can be up to 72 hours. In this project, patients who undergo elective laparoscopic uterine and double adnexectomy were selected to be injected with lipososomes of bupivacaine at different concentrations under ultrasound guidance of bilateral posterior QLB before anesthesia induction, and the effect of liposomal bupivacaine on postoperative pain was investigated by evaluating the postoperative pain and incidence of adverse events. This study will greatly promote the clinical promotion and application of bupivacaine liposome, improve the postoperative comfort and satisfaction of patients, and accelerate the postoperative recovery of patients.

NCT ID: NCT06288750 Recruiting - Indocyanine Green Clinical Trials

Protective Effect of Indocyanine Green Fluorescence Imaging Technology on Parathyroid Glands During Total Thyroidectomy

Start date: February 1, 2024
Phase: N/A
Study type: Interventional

Accurate identification and evaluation of the parathyroid glands (PGs) intraoperatively is critical to reduce the incidence of postoperative hypoparathyroidism after total thyroidectomy. Near-infrared fluorescence imaging (NIFI), including the autofluorescence (AF) and indocyanine green fluorescence (ICGF) imaging, is a promising technique to protect PGs. This study aimed to assess whether the combined use of AF and ICGF could reduce the incidence of postoperative hypoparathyroidism and improve the identification and evaluation of PGs during total thyroidectomy.

NCT ID: NCT06288659 Recruiting - Clinical trials for Aneurysmal Subarachnoid Hemorrhage

aSAH Treatment Based on Intraventricular ICP Monitoring: A Prospective, Multicenter, Randomized and Controlled Trial

ASTIM-MT
Start date: May 20, 2024
Phase: N/A
Study type: Interventional

ASTIM is a multicenter, prospective, randomised, blinded end-point assessed trial, to investigate the efficacy and safety of treatment based on intracranial pressure monitoring in improving the prognosis of patients with aneurysmal subarachnoid hemorrhage.

NCT ID: NCT06288620 Recruiting - Breast Cancer Clinical Trials

Microwave Ablation in the Treatment of Early-stage Unifocal Invasive Breast Cancer

Start date: February 25, 2024
Phase: N/A
Study type: Interventional

Microwave Ablative (MWA) therapy, as a minimally invasive thermal therapy, has been attempted to treat breast cancer of small lesions . However, the optimal indications for MWA in the treatment of breast cancer is unknown. This prospective, open-label, single-arm phase II clinical study was conducted to evaluate the efficacy and safety of MWA in the treatment of early-stage unifocal invasive breast cancer, and to explore the immune activating effect.